Literature DB >> 2834037

Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications.

H C Hsu1, T T Wu, M Z Wu, J C Sheu, C S Lee, D S Chen.   

Abstract

In order to elucidate the biologic behavior of hepatocellular carcinoma (HCC), the long-term prognostic impact of the pathologic features of 143 surgically resected HCC were studied. Seventy-four were smaller than 5 cm in diameter (small HCC), and 69 were larger (large HCC). This study confirmed that tumor size was an important but not the only determining prognostic factor in HCC. Although cirrhosis could cause hepatic failure, patient mortality was mainly attributable to tumor recurrence, which, in turn, was strongly correlated with the invasive nature of HCC. Tumor invasion to the liver and the intraportal spread were very frequent and particularly extensive in large HCC. In both small and large HCC the noninvasive groups not only had high 4-year actuarial survival (84.6% and 90%, respectively), but there was also no patient mortality from intrahepatic tumor recurrence. Therefore, it was concluded that invasiveness of an HCC is the most crucial factor in determining the long-term outcome for the patient, and that the clinical course of resected HCC is predictable in a great majority of the cases. In our small HCC series only 2.4% of HCC were regarded as having true multicentric origin. These findings suggest that the majority of HCC occur unicentrically, and that multiplicity and tumor recurrence result mostly from intrahepatic dissemination. In both small and large HCCs invasive tumors were accompanied by high patient mortality from tumor recurrence even when the tumor was small, indicating that intrahepatic spread may start very early during the growth of HCC.

Entities:  

Mesh:

Year:  1988        PMID: 2834037     DOI: 10.1002/1097-0142(19880515)61:10<2095::aid-cncr2820611027>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Myofibroblasts in hepatitis B related cirrhosis and hepatocellular carcinoma.

Authors:  K Y Chau; M A Lily; P C Wu; W L Yau
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

2.  Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience.

Authors:  E C Lai; I O Ng; K T You; S T Fan; F P Mok; E S Tan; J Wong
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

3.  Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma.

Authors:  X D Zhou; Z Y Tang; Y Q Yu; B H Yang; J Z Lu; Z Y Lin; Z C Ma; B H Zhang
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions.

Authors:  R C Karl; J Choi; T J Yeatman; R A Clark
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

5.  The pathological basis of resection margin for hepatocellular carcinoma.

Authors:  E C Lai; K T You; I O Ng; T W Shek
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

6.  Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.

Authors:  Zhong-Zhe Lin; Yung-Ming Jeng; Fu-Chang Hu; Hung-Wei Pan; Hsin-Wei Tsao; Po-Lin Lai; Po-Huang Lee; Ann-Lii Cheng; Hey-Chi Hsu
Journal:  BMC Cancer       Date:  2010-08-28       Impact factor: 4.430

7.  Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein.

Authors:  Y Yamaoka; K Kumada; K Ino; T Takayasu; Y Shimahara; K Mori; A Tanaka; T Morimoto; Y Taki; M Washida
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

8.  Repeat operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: a comparison with transcatheter arterial chemoembolization.

Authors:  K S Jeng; F S Yang; H J Chiang; I Ohta
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

9.  Hepatic resection versus transplantation for hepatocellular carcinoma.

Authors:  S Iwatsuki; T E Starzl; D G Sheahan; I Yokoyama; A J Demetris; S Todo; A G Tzakis; D H Van Thiel; B Carr; R Selby
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

10.  Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.

Authors:  Haluk Yuzugullu; Khemais Benhaj; Nuri Ozturk; Serif Senturk; Emine Celik; Asli Toylu; Nilgun Tasdemir; Mustafa Yilmaz; Esra Erdal; Kamil Can Akcali; Nese Atabey; Mehmet Ozturk
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.